These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30663561)

  • 1. The Biotin Biosynthetic Pathway in Mycobacterium tuberculosis is a Validated Target for the Development of Antibacterial Agents.
    Bockman MR; Mishra N; Aldrich CC
    Curr Med Chem; 2020; 27(25):4194-4232. PubMed ID: 30663561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of marine natural products for potential inhibitors targeting biotin biosynthesis pathway in
    Alamri MA; Ahmad S; Alqahtani SM; Irfan M; Alabbas AB; Tahir Ul Qamar M
    J Biomol Struct Dyn; 2023; 41(17):8535-8543. PubMed ID: 36264105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Biotin in Bacterial Physiology and Virulence: a Novel Antibiotic Target for Mycobacterium tuberculosis.
    Salaemae W; Booker GW; Polyak SW
    Microbiol Spectr; 2016 Apr; 4(2):. PubMed ID: 27227307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tryptophan biosynthetic pathway is essential for Mycobacterium tuberculosis to cause disease.
    Lott JS
    Biochem Soc Trans; 2020 Oct; 48(5):2029-2037. PubMed ID: 32915193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotin biosynthesis in Mycobacterium tuberculosis: physiology, biochemistry and molecular intervention.
    Salaemae W; Azhar A; Booker GW; Polyak SW
    Protein Cell; 2011 Sep; 2(9):691-5. PubMed ID: 21976058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development.
    Moraes GL; Gomes GC; Monteiro de Sousa PR; Alves CN; Govender T; Kruger HG; Maguire GE; Lamichhane G; Lameira J
    Tuberculosis (Edinb); 2015 Mar; 95(2):95-111. PubMed ID: 25701501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis.
    Bhat ZS; Rather MA; Maqbool M; Lah HU; Yousuf SK; Ahmad Z
    Biomed Pharmacother; 2017 Nov; 95():1520-1534. PubMed ID: 28946393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Methylerythritol Phosphate Pathway: Promising Drug Targets in the Fight against Tuberculosis.
    Wang X; Dowd CS
    ACS Infect Dis; 2018 Mar; 4(3):278-290. PubMed ID: 29390176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron Acquisition Pathways as Targets for Antitubercular Drugs.
    Meneghetti F; Villa S; Gelain A; Barlocco D; Chiarelli LR; Pasca MR; Costantino L
    Curr Med Chem; 2016; 23(35):4009-4026. PubMed ID: 27281295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics of cell wall biosynthesis in Mycobacterium tuberculosis.
    Goude R; Parish T
    Future Microbiol; 2008 Jun; 3(3):299-313. PubMed ID: 18505396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel class of small compounds with anti-tuberculosis activity by in silico structure-based drug screening.
    Taira J; Morita K; Kawashima S; Umei T; Baba H; Maruoka T; Komatsu H; Sakamoto H; Sacchettini JC; Aoki S
    J Antibiot (Tokyo); 2017 Nov; 70(11):1057-1064. PubMed ID: 28951604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotin, a universal and essential cofactor: synthesis, ligation and regulation.
    Sirithanakorn C; Cronan JE
    FEMS Microbiol Rev; 2021 Aug; 45(4):. PubMed ID: 33428728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium sulfur metabolism and implications for novel drug targets.
    Zeng L; Shi T; Zhao Q; Xie J
    Cell Biochem Biophys; 2013 Mar; 65(2):77-83. PubMed ID: 23054909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
    Anishetty S; Pulimi M; Pennathur G
    Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UDP-GlcNAc pathway: Potential target for inhibitor discovery against M. tuberculosis.
    Rani C; Khan IA
    Eur J Pharm Sci; 2016 Feb; 83():62-70. PubMed ID: 26690048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMAR_2770, a new enzyme involved in biotin biosynthesis, is essential for the growth of Mycobacterium marinum in macrophages and zebrafish.
    Yu J; Niu C; Wang D; Li M; Teo W; Sun G; Wang J; Liu J; Gao Q
    Microbes Infect; 2011 Jan; 13(1):33-41. PubMed ID: 20974274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.